Real-time enrollment status for this diffuse large b cell lymphoma clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 1:05 AM UTC
| NCT Number | NCT04502394 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B Cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 84 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Kartos Therapeutics, Inc. |
| Last Updated on CT.gov | August 4, 2022 (Aug 4, 2022) |
As of September 1, 2026: Clinical trial NCT04502394 is currently recruiting participants. This phase1 study for diffuse large b cell lymphoma is actively seeking new participants at 4 locations across the United States. The study is sponsored by Kartos Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04502394 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04502394 was last updated Aug 4, 2022 (August 4, 2022). HelloStudys verifies this status automatically.